Does TOCILIZUMAB Cause Pulmonary embolism? 801 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 801 reports of Pulmonary embolism have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.8% of all adverse event reports for TOCILIZUMAB.
801
Reports of Pulmonary embolism with TOCILIZUMAB
0.8%
of all TOCILIZUMAB reports
174
Deaths
525
Hospitalizations
How Dangerous Is Pulmonary embolism From TOCILIZUMAB?
Of the 801 reports, 174 (21.7%) resulted in death, 525 (65.5%) required hospitalization, and 371 (46.3%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 801 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which TOCILIZUMAB Alternatives Have Lower Pulmonary embolism Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE